Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:EYPT NASDAQ:NVMI NYSE:OUST On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEYPTEyepoint Pharmaceuticals$13.25-2.7%$12.16$3.91▼$14.91$913.32M1.95829,971 shs1.13 million shsNVMINova$312.87-5.5%$279.71$153.99▼$336.95$9.20B1.76312,878 shs330,472 shsOUSTOuster$32.69+0.8%$28.85$6.16▼$36.25$1.89B2.722.27 million shs3.02 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEYPTEyepoint Pharmaceuticals-0.80%-3.06%-2.78%+36.88%+57.82%NVMINova+2.78%+6.39%+29.44%+17.22%+63.37%OUSTOuster+8.61%+17.41%+18.06%+40.09%+408.31%Compare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeEYPTEyepoint Pharmaceuticals$13.25-2.7%$12.16$3.91▼$14.91$913.32M1.95829,971 shs1.13 million shsNVMINova$312.87-5.5%$279.71$153.99▼$336.95$9.20B1.76312,878 shs330,472 shsOUSTOuster$32.69+0.8%$28.85$6.16▼$36.25$1.89B2.722.27 million shs3.02 million shsA Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for October 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceEYPTEyepoint Pharmaceuticals-0.80%-3.06%-2.78%+36.88%+57.82%NVMINova+2.78%+6.39%+29.44%+17.22%+63.37%OUSTOuster+8.61%+17.41%+18.06%+40.09%+408.31%Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceEYPTEyepoint Pharmaceuticals 2.75Moderate Buy$26.86102.70% UpsideNVMINova 2.67Moderate Buy$282.50-9.71% DownsideOUSTOuster 3.00Buy$15.95-51.22% DownsideCurrent Analyst Ratings BreakdownLatest EYPT, NVMI, and OUST Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails9/27/2025EYPTEyepoint PharmaceuticalsWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingSell (D-)9/27/2025NVMINovaWeiss RatingsSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingHold (C)8/13/2025OUSTOusterWestpark CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingUpgradeHold ➝ Buy8/7/2025EYPTEyepoint PharmaceuticalsChardan CapitalSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingReiterated RatingBuy$27.008/6/2025EYPTEyepoint PharmaceuticalsHC WainwrightSubscribe to MarketBeat All Access for the firm's recommendation accuracy ratingBoost Price TargetBuy$22.00 ➝ $23.00(Data available from 10/7/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookEYPTEyepoint Pharmaceuticals$43.27M21.11N/AN/A$4.93 per share2.69NVMINova$807.09M11.40$6.79 per share46.05$31.69 per share9.87OUSTOuster$125.85M15.02N/AN/A$4.15 per share7.88Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateEYPTEyepoint Pharmaceuticals-$130.87M-$2.68N/AN/AN/A-337.93%-63.80%-50.72%11/6/2025 (Estimated)NVMINova$183.76M$7.3542.5738.822.6729.10%24.36%16.66%11/6/2025 (Estimated)OUSTOuster-$374.11M-$1.82N/AN/AN/A-106.50%-65.17%-37.02%11/6/2025 (Estimated)Latest EYPT, NVMI, and OUST EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails8/7/2025Q2 2025NVMINova$2.05$2.20+$0.15$2.14$214.95 million$219.99 million8/6/2025Q2 2025EYPTEyepoint Pharmaceuticals-$0.67-$0.85-$0.18-$0.85$6.82 million$5.33 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthEYPTEyepoint PharmaceuticalsN/AN/AN/AN/AN/ANVMINovaN/AN/AN/AN/AN/AOUSTOusterN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioEYPTEyepoint PharmaceuticalsN/A8.007.91NVMINovaN/A2.572.05OUSTOusterN/A3.122.83Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipEYPTEyepoint Pharmaceuticals99.41%NVMINova82.99%OUSTOuster31.45%Insider OwnershipCompanyInsider OwnershipEYPTEyepoint Pharmaceuticals4.46%NVMINova1.00%OUSTOuster6.63%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableEYPTEyepoint Pharmaceuticals12068.93 million65.85 millionOptionableNVMINova4,14929.40 million29.11 millionOptionableOUSTOuster28057.82 million45.88 millionOptionableEYPT, NVMI, and OUST HeadlinesRecent News About These CompaniesWinsome Earle-Sears releases ‘Two Bullets’ ad scathing opponent for failing to demand Jay Jones’ ouster1 hour ago | msn.comAbilene residents slam Trump ouster of Eisenhower museum leader over sword: ‘It's crap!'October 7 at 1:57 PM | msn.comWill Dolphins fire Mike McDaniel? NFL insider gives timeline for possible ousterOctober 7 at 1:57 PM | sports.yahoo.comSyria announces results of 1st parliamentary elections since Assad’s ousterOctober 6 at 7:28 PM | trtworld.comTSyria unveils results of 1st parliamentary vote since Assad’s ousterOctober 6 at 7:28 PM | dailysabah.comDOuster: Irrational Exuberance Behooves Caution NowOctober 6 at 10:04 AM | seekingalpha.comPNP: No talks to withdraw support from Marcos amid ouster rumorsOctober 5 at 12:54 AM | msn.comSyria holds first parliamentary election since Assad's ouster, marking a major step toward 'reforms'October 5 at 12:54 AM | indiatvnews.comIWhat to expect as Syria holds first parliamentary elections since Assad's ousterOctober 5 at 7:54 PM | npr.orgNSyria holds first elections since Assad's ouster, marking a cautious step in political transitionOctober 5 at 7:54 PM | msn.comWhat to expect as Syria goes to polls for first time since Assad's ousterOctober 5 at 3:49 AM | thehindubusinessline.comNYC police union calls for ouster of Mamdani-esque Civilian Complaint Review Board chairOctober 4 at 10:48 PM | msn.comNYC police union calls for ouster of ‘anti-cop’ Mamdani-esque Civilian Complaint Review Board chairOctober 4 at 3:22 PM | msn.comPure Financial Advisors LLC Invests $357,000 in Ouster, Inc. $OUSTOctober 4 at 4:04 AM | marketbeat.comOuster: Taking Profits, But Shares Are Still A 'Hold'October 4 at 2:33 AM | seekingalpha.comFired NIAID Director Claims Ouster was Payback for Whistleblower ReportOctober 3, 2025 | biospace.comBSyria to hold first parliament vote since Assad ouster, raising inclusivity concernsOctober 3, 2025 | msn.comHow Syria's first elections since autocrat Assad's ouster is expected to unfoldOctober 2, 2025 | msn.comPadres' sturdy bullpen never gets a lead to protect in playoff ousterOctober 2, 2025 | mlb.comMHow Syria's first elections since autocrat Assad's ouster are expected to unfoldOctober 2, 2025 | abcnews.go.comHow Syria’s first elections since autocrat Assad’s ouster are expected to unfoldOctober 2, 2025 | fox21online.comFNew MarketBeat Followers Over TimeMedia Sentiment Over TimeEYPT, NVMI, and OUST Company DescriptionsEyepoint Pharmaceuticals NASDAQ:EYPT$13.25 -0.37 (-2.72%) Closing price 04:00 PM EasternExtended Trading$13.68 +0.43 (+3.25%) As of 07:06 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.Nova NASDAQ:NVMI$312.87 -18.11 (-5.47%) Closing price 04:00 PM EasternExtended Trading$321.24 +8.37 (+2.67%) As of 06:55 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Nova Ltd. designs, develops, produces, and sells process control systems used in the manufacture of semiconductors in Israel, Taiwan, the United States, China, Korea, and internationally. Its product portfolio includes a set of metrology platforms for dimensional, films, and materials and chemical metrology measurements for process control for various semiconductor manufacturing process steps, including lithography, etch, chemical mechanical planarization, deposition, electrochemical plating, and advanced packaging. The company serves various sectors of the integrated circuit manufacturing industry, including logic, foundries, and memory manufacturers, as well as process equipment manufacturers. Nova Ltd. was formerly known as Nova Measuring Instruments Ltd. and changed its name to Nova Ltd. in July 2021. Nova Ltd. was incorporated in 1993 and is headquartered in Rehovot, Israel.Ouster NYSE:OUST$32.69 +0.26 (+0.80%) Closing price 04:00 PM EasternExtended Trading$32.88 +0.19 (+0.58%) As of 07:14 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.Ouster, Inc. provides lidar sensors for the automotive, industrial, robotics, and smart infrastructure industries in Americas, the Asia-Pacific, Europe, the Middle East, and Africa. Its products include high-resolution scanning and solid-state digital lidar sensors, analog lidar sensors, and software solutions. The company offers Ouster Sensor, a scanning sensor; and Digital Flash, a solid-state flash sensor. It also provides surround-view lidar sensors, which include Ouster Gemini, a perception platform for smart infrastructure deployments; and Blue City, a Gemini-powered solution for traffic operations, planning, and safety. The company is headquartered in San Francisco, California. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30DroneEcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerFlying CarGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMade In AmericaMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUraniumUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector 3 Dividend Aristocrats to Buy Before Year’s End The Juice Is Loose: Why Plug Power's Rally Is Just the Beginning Joby's Stock Rallies as Public Flights Validate Global Game Plan SharkNinja Is Flashing a Buy Signal the Market Is Ignoring Why Semtech Stock Is Rallying After Its NVIDIA Setback Marvell Insiders Buy Shares—Should Investors Follow Suit? Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
